Bionano Genomics Inc Market Cap ($13.90 Million)
Market Cap & Net Worth: Bionano Genomics Inc (BNGO)
Bionano Genomics Inc market cap. Bionano Genomics Inc (NASDAQ:BNGO) has a market capitalization of $13.90 Million ($13.90 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26052 globally and #5482 in its home market, demonstrating a 3.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bionano Genomics Inc's stock price $1.20 by its total outstanding shares 11777000 (11.78 Million). Also see cash efficiency ratio of Bionano Genomics Inc for how efficiently the company converts equity into cash flow.
Bionano Genomics Inc Market Cap History (2018–2026)
Bionano Genomics Inc market cap history from 2018 to 2026. Data shows change from $617.11 Million to $14.13 Million (-39.37% CAGR). Check latest Bionano Genomics Inc stock price today for real-time trading data and today's change.
Index Memberships
Bionano Genomics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #729 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2386 of 3165 |
Weight: Bionano Genomics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bionano Genomics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bionano Genomics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Bionano Genomics Inc annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.63x
Bionano Genomics Inc's market cap is 0.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $617.11 Million | $12.00 Million | -$18.50 Million | 51.42x | N/A |
| 2019 | $146.03 Million | $10.13 Million | -$29.84 Million | 14.42x | N/A |
| 2020 | $362.73 Million | $8.50 Million | -$41.14 Million | 42.66x | N/A |
| 2021 | $352.13 Million | $17.98 Million | -$72.44 Million | 19.58x | N/A |
| 2022 | $171.94 Million | $27.80 Million | -$132.60 Million | 6.18x | N/A |
| 2023 | $22.26 Million | $36.12 Million | -$232.49 Million | 0.62x | N/A |
| 2024 | $3.40 Million | $30.78 Million | -$112.02 Million | 0.11x | N/A |
| 2025 | $18.02 Million | $28.51 Million | -$26.39 Million | 0.63x | N/A |
Competitor Companies of BNGO by Market Capitalization
Companies near Bionano Genomics Inc in the global market cap rankings as of November 5, 2026. Also see Bionano Genomics Inc (BNGO) total assets for a full breakdown of the balance sheet.
Key companies related to Bionano Genomics Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.74 Billion USD ( €85.32 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #418 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #535 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $440.75 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.74 Billion | €184.25 |
| #418 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €91.50 |
| #535 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Bionano Genomics Inc (2018–2026)
Market capitalization of Bionano Genomics Inc from 2018 to today. Between 2018 and today, Bionano Genomics Inc's market cap moved from $617.11 Million to $ 14.13 Million, with a yearly change of -39.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $14.13 Million | -21.57% |
| 2025 | $18.02 Million | +430.51% |
| 2024 | $3.40 Million | -84.74% |
| 2023 | $22.26 Million | -87.05% |
| 2022 | $171.94 Million | -51.17% |
| 2021 | $352.13 Million | -2.92% |
| 2020 | $362.73 Million | +148.39% |
| 2019 | $146.03 Million | -76.34% |
| 2018 | $617.11 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Bionano Genomics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.90 Million USD |
| MoneyControl | $13.90 Million USD |
| MarketWatch | $13.90 Million USD |
| marketcap.company | $13.90 Million USD |
| Reuters | $13.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bionano Genomics Inc
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simpl… Read more